API
< Back to all clusters
[TECHNOLOGY] · Austria, Denmark, Germany, United States · 2 sources

started · updated

Space medicine research addresses health risks in microgravity

Recent scientific investigations are addressing significant physiological challenges faced by astronauts in microgravity, which could impact long-duration missions to the Moon and Mars.

The European Space Agency (ESA) identifies thrombosis as a major health risk. Due to weightlessness, blood does not return to the heart as efficiently as on Earth, causing it to pool in the jugular veins or flow back toward the brain. Unlike terrestrial thrombosis, which typically affects the legs, space-related cases primarily involve the neck. Researchers, including ESA reserve astronaut Carmen Possnig, have utilized parabolic flights to study these circulation disruptions. Current mitigation strategies include regular ultrasound monitoring and the potential use of blood thinners, though the latter carries increased bleeding risks.

Additionally, a collaborative study by the University of Copenhagen and NASA has identified the biological mechanism behind digestive issues on the International Space Station (ISS). Analysis of blood samples from 52 crew members revealed that microgravity significantly slows intestinal peristalsis, the muscle contractions that move food through the digestive tract. This extended transit time disrupts the balance of gut bacteria, as microorganisms consume available nutrients before the food can be fully processed.

Entities

Carmen Possnig · European Space Agency · International Space Station · NASA · University of Copenhagen